PCMH
RMD icon

Polymer Capital Management (HK)’s ResMed RMD Stock Holding History

Polymer Capital Management (HK)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000
Closed -$396K – 230
2024
Q1 		$396K Hold
2,000
– – 0.1% 121
2023
Q4 		$344K Buy
+2,000
New +$307K 0.12% 103

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polymer Capital Management (HK)'s RMD Position: Q2 2024 in Review

Polymer Capital Management (HK) sold out of ResMed (RMD) in Q2 2024, closing a stake of 2,000 shares — an estimated $396K sold.

Polymer Capital Management (HK) first reported a position in RMD in Q4 2023 and held it in 2 quarters. The position peaked at $396K in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Polymer Capital Management (HK) reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 2,000 ResMed shares in Q2 2024, an estimated $396K.
  • Polymer Capital Management (HK) first reported a position in ResMed in Q4 2023 and held it in 2 quarters.
  • Polymer Capital Management (HK)'s ResMed position peaked at $396K in Q1 2024.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Polymer Capital Management (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.